Consequences of Biomarker Analysis on the Cost-Effectiveness of Cetuximab in Combination with FOLFIRI as a First-Line Treatment of Metastatic Colorectal Cancer: Personalised Medici...

por Harty, Gerard, Jarrett, James, Jofre-Bonet, Mireia
Publicado 2018

An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing–Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-...

por Piena, Marjanne A., Kroep, Sonja, Simons, Claire, Fenwick, Elisabeth, Harty, Gerard T., Wong, Schiffon L., van Hout, Ben A.
Publicado 2021

Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands

por Michels, Renée Else, de Fransesco, Maria, Mahajan, Koshu, Hengstman, Gerald J. D., Schiffers, Krijn M. H., Budhia, Sangeeta, Harty, Gerard, Krol, Marieke
Publicado 2019

Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands

por Michels, Renée Else, De Francesco, Maria, Mahajan, Koshu, Hengstman, Gerald J. D., Schiffers, Krijn M. H., Budhia, Sangeeta, Harty, Gerard, Krol, Marieke
Publicado 2020